Products and Services
-
DPI developer Iconovo announced that it has received a $883,800 grant from the Bill & Melinda Gates Foundation for development of a nasal inhaler based on the company’s ICOone single dose device. In March 2021, Iconovo… Read more . . .
-
Hailie inhaler monitoring system maker Adherium announced that the FDA has cleared the company’s new version of the Hailie sensor for use with Ellipta dry powder inhalers. Adherium submitted the 510(k) application to the FDA… Read more . . .
-
Florida-based startup Transpire Bio announced that it has signed an agreement with Recipharm for development of two inhaled candidates, TRB-1 and TRB-2, for the treatment of asthma and COPD. The company says that the two… Read more . . .
-
German digital health company VisionHealth has announced that it will “cooperate on distribution of inhalation platform Kata” with Boehringer Ingelheim in Germany. The Kata app uses artificial intelligence and augmented reality technology in conjunction with… Read more . . .
-
TFF Pharmaceuticals announced that it has leased a new 3,500+ square foot R&D facility in Austin, Texas, USA, that will house additional lab space, as well as equipment for the production of preclinical supplies, significantly expanding… Read more . . .
-
DFE Pharma has announced the launch of a new product in its range of Lactohale inhalation grade lactose products; Lactohale 400 milled anhydrous lactose is described as a grade for formulations “where a relatively good… Read more . . .
-
Device maker H&T Presspart has announced the opening of a new laboratory scale facility at its Blackburn, UK Inhalation Product Technology Centre (IPTC) for filling metered dose inhalers with lower global warming potential (GWP) propellants, including… Read more . . .
-
Adherium has announced that Helicon Health, a spin out from the UCL Centre for Health Informatics and Multi Professional Education, will market Adherium’s Hailie inhaler sensors and monitoring service in the UK. According to the… Read more . . .
-
According to CounterAct, the Canadian Intellectual Property Office has issued a patent (3065307, “Prescription bottle cap capable of administering opioid overdose reversal agent”) covering the company’s naloxone nasal spray cap. CounterAct co-founder Todd Pizitz commented, “We are pleased… Read more . . .
-
Opiant Pharmaceuticals announced that it has signed an agreement with Aptar Pharma for expanded production of Aptar’s Unidose device in order to support potential commercial demand for Opiant’s OPNT003 intranasal nalmefene. The agreement includes €2… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland